← Open Payments lookup

SAID IBRAHIMI: Open Payments

NPI 1740560861 · DANVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$23,738 in 292 payments from 19 companies in 2025. Trend: 2023 $5,803 · 2024 $6,153 · 2025 $23,738

Honoraria: $14,600Food & beverage: $7,069Travel & lodging: $2,042Education: $27
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.35$17,663
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$753
Alkermes, Inc.20$643
SK Life Science, Inc.36$631
ABBVIE INC.23$565
E.R. Squibb & Sons, L.L.C.17$470
Otsuka America Pharmaceutical, Inc.15$428
Janssen Pharmaceuticals, Inc6$324
Takeda Pharmaceuticals U.S.A., Inc.22$312
Vanda Pharmaceuticals Inc.8$310

Products named: Qelbree, CAPLYTA, REXULTI, COBENFY, ARISTADA, VRAYLAR, TRINTELLIX, FANAPT.

Industry payments across CA — which companies pay providers there.